Skip to main content

Table 2 P-values of different genes in five studies selected in Oncomine

From: Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis

 CritchleyHaqqRikerTalantovTCGA
YTHDF10.1871.14 * 10−7
ELF30.2580.5160.8870.9993.86 * 10−7
HNRNPA2B10.8141.1970.0620.2462.64 * 10−10
YTHDF20.1170.3920.1820.0200.441
WTAP0.7940.1850.4001.000
METTL140.6710.8990.962
FTO0.1670.0350.2590.8180.989
ALKBH50.0920.6680.2110.995
HNRNPC0.2000.3222.68 * 10−50.943
METTL30.3490.0740.6500.944
  1. The results are from comparisons of patients with melanoma and healthy individuals. Critchley, Critchley-Thorne, et al., Plos Med (2007); Haqq, Christopher Haqq, et al., PNAS(2005); Riker, Adam I Riker, et al., BMC Med Genomics (2008); Talantov, Dmitri Talantov, et al., Human cancer biology (2005); TCGA, the cancer genome atlas (2013)